Alnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year by Healthcare Businesswomen’s Association
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, said today that Chief Executive Officer Yvonne Greenstreet has been selected as the 2024 Woman of the Year by the Healthcare Businesswomen’s Association (HBA).
- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, said today that Chief Executive Officer Yvonne Greenstreet has been selected as the 2024 Woman of the Year by the Healthcare Businesswomen’s Association (HBA).
- Yvonne will be recognized at HBA’s 34th annual Woman of the Year event on May 10 in New York City.
- The HBA Woman of the Year award honors an executive leader who has made extraordinary contributions to healthcare and the advancement of women in the workplace.
- “Yvonne demonstrates leadership from the front,” said David Pyott, retired chairman and CEO of Allergan and a member of Alnylam’s board of directors.